Bioxcel therapeutics to report second quarter 2023 financial results on august 14, 2023

New haven, conn., july 31, 2023 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its second quarter 2023 financial results on monday, august 14, 2023 before the open of the u.s. financial markets. bioxcel therapeutics' management team will also host a conference call and webcast at 8:00 am et that day to discuss the company's financial results and to provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking